Nantahala Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Nantahala Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-133,127	Closed	-$791K	–	145
2024 Q3	$791K	Sell	133,127 -25,367	-16%	-$127K	0.04%	117
2024 Q2	$761K	Sell	158,494 -41,325	-21%	-$260K	0.04%	111
2024 Q1	$1.44M	Sell	199,819 -2,530	-1%	-$19.1K	0.08%	93
2023 Q4	$1.92M	Sell	202,349 -5,984	-3%	-$44.1K	0.11%	89
2023 Q3	$1.11M	Buy	+208,333	New	+$1.4M	0.1%	102

Other funds holding NMTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Nantahala Capital Management's NMTC Position: Q4 2024 in Review

Nantahala Capital Management sold out of NeuroOne Medical Technologies (NMTC) in Q4 2024, closing a stake of 133,127 shares — an estimated $791K sold.

Nantahala Capital Management first reported a position in NMTC in Q3 2023 and held it in 5 quarters. The position peaked at $1.92M in Q4 2023. 20 funds tracked by Wall St. Rank hold NMTC as of Q4 2024.

Nantahala Capital Management reported no remaining NeuroOne Medical Technologies position as of Q4 2024 after selling out during the quarter.
Nantahala Capital Management sold 133,127 NeuroOne Medical Technologies shares in Q4 2024, an estimated $791K.
Nantahala Capital Management first reported a position in NeuroOne Medical Technologies in Q3 2023 and held it in 5 quarters.
Nantahala Capital Management's NeuroOne Medical Technologies position peaked at $1.92M in Q4 2023.
20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.